QMENTA News
Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and...
Top 7 Trends in Imaging Clinical Trials for 2025
The imaging clinical trials industry continues to grow in the face of unique challenges! To help you keep up, we’ve put together the top trends to...
Improving Multiple Sclerosis Diagnosis: Automating Central Vein Sign (CVS) Detection with QMENTA’s Imaging Hub
Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...
Unraveling Parkinson's: The Power of Neuroimaging Biomarkers
Advance Parkinson’s research with QMENTA's Imaging Hub: cutting-edge imaging, biomarker insights, and cloud-based tools for early detection and...
Central Vein Sign: A Breakthrough in Multiple Sclerosis Diagnosis, Redefining McDonald Criteria
Discover how the Central Vein Sign (CVS) may enhance diagnostic accuracy, advance research outcomes, and influence the McDonald criteria.
How to Incorporate AI Technology into Medical Imaging Workflows and Why You Should Do It
Discover how AI enhances medical imaging workflows, boosting accuracy and efficiency. Learn benefits, challenges, and how QMENTA simplifies AI...
Top 5 Trends in Neuroscience You Need to Know in 2025
Take a look ahead at our predicted trends for neuroscience in 2025 - where technology, neuroplasticity, and neuroethics are reshaping the way we...
Decoding the Brain's Balance: A Novel Workflow to Quantify Asymmetry in MRI
Discover insights into structural and functional aspects of the human brain, potential biomarkers, and applications in psychiatric research.